This brand name is authorized in United States. It is also authorized in Ecuador, Finland, Hong Kong SAR China, Ireland, Italy, Mexico, Netherlands, South Africa, Spain, Turkey, UK.
The drug LOPID contains one active pharmaceutical ingredient (API):
1
|
UNII
Q8X02027X3 - GEMFIBROZIL
|
|
Gemfibrozil is a lipid regulating agent which regulates lipid fractions. Gemfibrozil stimulates the peripheral lipolysis of triglyceride rich lipoproteins such as VLDL and cholymicrons by stimulation of LPL. Gemfibrozil also inhibits synthesis of VLDL in the liver. |
|
Below package inserts are available for further reading:
| Document | Type | Information Source | |
|---|---|---|---|
| LOPID Film-coated tablet | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| C10AB04 | Gemfibrozil | C Cardiovascular system → C10 Lipid modifying agents → C10A Lipid modifying agents, plain → C10AB Fibrates |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | 30038-11-11, 30046-11-11, 363311112 |
| ES | Centro de información online de medicamentos de la AEMPS | 58832, 61026 |
| FI | Lääkealan turvallisuus- ja kehittämiskeskus | 469346 |
| GB | Medicines & Healthcare Products Regulatory Agency | 13916, 143316, 162007, 209799, 373779 |
| HK | Department of Health Drug Office | 30985 |
| IE | Health Products Regulatory Authority | 31941, 32150, 54369 |
| IT | Agenzia del Farmaco | 025445026, 025445053 |
| MX | Comisión Federal para la Protección contra Riesgos Sanitarios | 107M84 |
| NL | Z-Index G-Standaard, PRK | 31062 |
| TR | İlaç ve Tıbbi Cihaz Kurumu | 8681308091222, 8681308091239 |
| US | FDA, National Drug Code | 0071-0737 |
| ZA | Health Products Regulatory Authority | Y/7.5/245 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.